Survival of Anti-Mitochondrial Antibody-Positive and -Negative Primary Biliary Cirrhosis Patients on Ursodeoxycholic Acid Treatment

被引：1
作者：
Meri Koulentaki
Joanna Moscandrea
Philipos Dimoulios
Costas Chatzicostas
Elias A. Kouroumalis
机构：
[1] University Hospital Heraklion,The Department of Gastroenterology
来源：
Digestive Diseases and Sciences | 2004年 / 49卷
关键词：
primary biliary cirrhosis; autoimmune cholangitis; anti-mitochondrial antibodies; ursodeoxycholic acid; treatment; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The survival of 85 anti-mitochondrial antibody (AMA)-positive (mean Mayo risk score, 5.11) and 19 AMA-negative (mean Mayo risk score, 4.77) primary biliary cirrhosis patients, under ursodeoxycholic acid not subjected to liver transplantation, was compared with the estimated survival of a simulated control group of untreated patients created with the updated Mayo model and a control group from the general population. In the first 7 years 3 AMA-negative patients died, versus 12 under the Mayo model (P=0.01), and 10 AMA-positive patients, versus 26 under the Mayo model (P<0.005), with 7 expected deaths from the general population (P<0.0001). At 10 years the cumulative survival differed in the treated patients overall (P<0.0001) but not in the early primary biliary cirrhosis (stages I–II) patients compared to the general population. Therefore the survival of our patients treated with ursodeoxycholic acid is higher than that predicted from the Mayo model. Early treatment may prolong survival.
引用
收藏
页码：1190 / 1195
页数：5
相关论文
共 183 条
  • [11] Wesierska-Gadek J(2002)Ursodeoxycholic acid for primary biliary cirrhosis: Final results of a 12-year, prospective, randomized, controlled trial Am J Gastroenterol 97 2063-2070
  • [12] Reynoso-Paz S(2003)Combined analyses of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis J Hepatol 39 12-16
  • [13] Gershwin ME(1978)Staging of chronic nonsuppurative cholangitis (syndrome of primary biliary cirrhosis) Virchows Arch 379 103-112
  • [14] Anderson J(1989)Prognosis in primary biliary cirrhosis: model for decision making Hepatology 10 1-7
  • [15] Jois JA(1996)Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis Gastroenterology 110 1515-1518
  • [16] Ikuno N(1996)Reply to letter: Survival in ursodeoxycholic acid-treated patients with biliary cirrhosis by Bonnand AM, Poupon RE Gastroenterology 111 1782-1783
  • [17] Scealy M(1991)A note on the calculation of expected survival, illustrated by the survival of liver transplant patients Stat Med 10 733-738
  • [18] Davies JM(1992)Letter to the Editor A note on the calculation of expected survival, illustrated by survival of liver transplant patients by Thomsen BL et al. Stat Med 11 1527-1532
  • [19] Whittingham SF(1958)Non-parametric estimation from incomplete observations J Am Stat Assoc 53 457-481
  • [20] Omagari K(1981)Rank tests and a one-sample log rank test for comparing observed survival data to a standard population Biometrics 37 632-640
12345678910